The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Serious adverse events among a population-based cohort of patients receiving first-line chemotherapy for metastatic colorectal cancer (mCRC).
Raymond Woo-Jun Jang
No relevant relationships to disclose
Katherine Enright
No relevant relationships to disclose
Christopher M. Booth
No relevant relationships to disclose
Kelvin K. Chan
No relevant relationships to disclose
Lingsong Yun
No relevant relationships to disclose
Monika K. Krzyzanowska
No relevant relationships to disclose